Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 15,2018
Engineered DNA-Encoded mAbs Successfully Target Zaire Ebolavirus
Researchers at The Wistar Institute and colleagues say they have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Their study ("In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model”), published online in Cell Reports, showed that DMAbs were expressed overRead more
More
Engineered DNA-Encoded mAbs Successfully Target Zaire Ebolavirus
Nov 14,2018
High-Protein Diet Exposes Cancer Stem Cells to New Drug Approach
Unlike healthy cells or mature cancer cells, the stem cells that sustain cancer rely on energy derived from protein or, more precisely, amino acids. This unique dietary preference, say scientists based at the University of Colorado Cancer Center, makes cancer stem cells uniquely vulnerable to drugs that inhibit amino acid uptake. Such drugs could killRead more
More
Nov 14,2018
Gut Microbiome Bacteria Provides Link Between Fiber and Heart Health
Fiber, fiber, and more fiber! If you want to have a healthy gut and strong heart you must eat your fiber – at least that's what the inundating marketing campaigns tell us on a daily basis. Thankfully, most scientific evidence also currently supports that diets rich in fiber are associated with an array of positiveRead more
More
Gut Microbiome Bacteria Provides Link Between Fiber and Heart Health
Nov 13,2018
Autism-Zinc Link Mechanistically Defined
Researchers say they have defined a possible mechanistic link that explains how zinc deficiency could contribute to autism. Their study ("Shank and Zinc Mediate an AMPA Receptor Subunit Switch in Developing Neurons”), published in Frontiers in Molecular Neuroscience, shows how zinc shapes the synapses between brain cells that form during early development, via a complexRead more
More
Nov 13,2018
Asymptomatic Brain Injury Linked to Atrial Fibrillation
Researchers from the Intermountain Medical Center Heart Institute in Salt Lake City have found that patients with atrial fibrillation (AF) also show signs of asymptomatic brain injury. They reported the results of their study at the American Heart Association Scientific Session conference in Chicago.   The team enrolled 246 patients in the study: 198 with atrialRead more
More
Nov 12,2018
Team Shows How Cancer Suppressor AMPK Can Also Help Tumors Grow
Long thought to suppress cancer by slowing cellular metabolism, the protein complex AMPK also seemed to help some tumors grow, confounding researchers. Now, Salk Institute researchers have solved the long-standing mystery around why AMPK can both hinder and help cancer. For more details about Medicilon's tumor model. The lab of Reuben Shaw, Ph.D., director ofRead more
More
Team Shows How Cancer Suppressor AMPK Can Also Help Tumors Grow
Nov 12,2018
Chlamydia Attacks with Frankenstein Protein
Scientists at the MRC Laboratory of Molecular Biology in the U.K., and Duke University in the U.S., report new insights into the mechanisms by which the pathogenic bacterium Chlamydia trachomatis hijacks the human host cells in which it replicates. Their finding, which they say "unveils a remarkable case of protein moonlighting,” suggests that one ChlamydiaRead more
More
Nov 09,2018
Response to Immunotherapy Predicted by Extracellular Matrix Genes
Immunotherapy has been a life-saving intervention for an array of diseases, particularly cancer. However, the treatments are not suited for every patient and can lead to serious side effects and even death. Understanding which patients would be best served by immunotherapy treatments is quickly becoming an essential factor in designing treatment strategies. As such, investigatorsRead more
More
Nov 09,2018
CRISPR-Cas9 without Donor Templates Still Accomplishes DNA Repair
CRISPR-Cas9 has the reputation for being "snip happy,” for cutting and cutting a genomic site until one of the cell's DNA repair systems finally skips a beat, leaving the site imperfectly repaired – scarred, really. Although scarred DNA has its purposes, it isn't the same thing as precisely edited DNA. According to a new studyRead more
More
Nov 08,2018
Drug-Resistant Bacteria May Succumb to Antibiotic-Polypeptide Conjugates
Peptides and proteins incorporating an unusual amino acid, selenocysteine, easily conjugate with small molecules – including antibiotics to which bacteria have become resistant. Fortunately, selenocysteine appears capable of giving such antibiotics an extra boost, report scientists based at MIT. These scientists showed that a selenocysteine-containing peptide enhanced the effectiveness of the antibiotic vancomycin against twoRead more
More
Drug-Resistant Bacteria May Succumb to Antibiotic-Polypeptide Conjugates
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->